Common epilepsy drug levetiracetam presents potential clot risk for patients taking blood thinners
Researchers from the University of Liverpool and the University of Zurich have identified a potential safety consideration involving levetiracetam, one of the world's most commonly prescribed antiseizure medications.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.